50% off the $29.99 Customized Fix Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
In re EpiPen Marketing, Sales Practices and Antitrust Litigation
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. In re EpiPen Marketing, Sales Practices and Antitrust Litigation just got measured.
4/10 means In re EpiPen Marketing, Sales Practices and Antitrust Litigation is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About In re EpiPen Marketing, Sales Practices and Antitrust Litigation
Toggle navigation Home Pfizer Settlement Long Form Notice / FAQ Court Documents Claim Forms Español Contact MARCH 26, 2026 UPDATE: The Settlement Administrator is commencing the second distribution to eligible claimants.
Details
Industry: Legal
epipenclassaction.comAI Visibility Breakdown
1
Structured Data
3
Content Structure
6
Entity Clarity
4
E-E-A-T Signals
5
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for In re EpiPen Marketing, Sales Practices and Antitrust Litigation.
Source & Attribution
Scored by Engagemii on July 7, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/epipenclassaction
Cite this score: Engagemii (2026). "AEO Score for In re EpiPen Marketing, Sales Practices and Antitrust Litigation." Retrieved from https://engagemii.com/aeo/brands/epipenclassaction
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform